Johnson & Johnson CEO Joaquin Duato on Fighting Cancer, AI and Medical Innovation
About this episode
Joaquin Duato discusses healthcare challenges and innovations at the 2026 WSJ CEO Council Summit.
On this Leaders episode, recorded at the 2026 WSJ CEO Council Summit in London, Johnson & Johnson Chairman and CEO Joaquin Duato joins WSJ Leadership Institute President Alan Murray to discuss the company's focus on tackling some of healthcare's most complex challenges, breakthroughs in cancer treatment, the future of longevity, and the role AI is playing in accelerating medical innovation. Recorded on June 10, 2026.
More episodes of WSJ Leadership Institute Presents: Leaders
- Dow Jones CEO Almar Latour on AI Disruption, Media Trust and the Value of Information
- James Vowles on Rebuilding Williams Racing and the Formula for Transformation
- From $1 Cosmetics to a Multi-Billion Dollar Beauty Empire with e.l.f. CEO Tarang Amin
- Inside Marriott CEO Anthony Capuano’s Strategy to Win Customers—and Keep Them
- Delta Air Lines CEO Ed Bastian on Crisis Management and the Airline Industry’s Future
- Why Unilever CEO Fernando Fernandez Wants an Influencer in Every Zip Code
Explore listener stats, chart rankings, contacts and more on the WSJ Leadership Institute Presents: Leaders podcast page.